Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial
Anthony Mills,Giuliano Rizzardini,Moti Ramgopal,Olayemi Osiyemi,Johannes R. Bogner,Debbie Hagins,Roger Paredes,Jacques Reynes,Jürgen K. Rockstroh,Andrew Carr,Feng-Hsiu Su,Stephanie O. Klopfer,Karen Eves,Rebeca M. Plank,Todd Correll,Michelle C. Fox
出处
期刊：The Lancet HIV [Elsevier BV] 日期：2024-05-08卷期号：11 (6): e357-e368被引量：23
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
大力的冬萱
Avalonx
cdercder
ale
arniu2008
科研狗
潇洒的惋清
sagitar
weixia
行走的荷尔蒙
科研啦
OK
liuzhuohao
天晴
卡乐瑞咩吹可
lx
yyyy
愉快的真
挖掘机
皖公网安备34019202002308
